GLP-1 medications help manage diabetes and encourage weight loss
PP exerts its effects through the specific receptors (Y1-Y5) and exhibits inhibitory action on pancreatic secretion (55, 56) and gastrointestinal motility (57)
Dietary modifications, urinary tract infections, and improved glycaemic control can all contribute to changes in urine characteristics
However, the novel uptake signatures observed in patients on GLP-1 agonistseven in non-malignant tissues like skeletal muscle, myocardium, and brown adipose tissueraise the specter of false-positive results, potentially mimicking aggressive neoplastic or inflammatory pathologies
Isolation of positive modulator of glucagon-like peptide-1 signaling from trigonella foenum-graecum (Fenugreek) seed
Insurance requirements: Some insurance plans require an in-person evaluation before authorizing coverage for GLP-1 medications